Delivery Order SPE2DB22D1202-SPE2DB24FUTR5
- Not listed
- This contract award, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for the treatment of gastrointestinal conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 31, 2023. The contract does not have a...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ19P, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,103.83 firm-fixed-price delivery order contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $23,088.68 firm fixed-price delivery order is for the supply of 4,564,299,048 units of sucralfate 1 gram tablets, with an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.63, is for the delivery of CARAFATE 1 GM TABLET 100S, a medical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,929.45 firm fixed price delivery order is for the supply of 420 ml bottles of 1 gram/10 ml sucralfate suspension. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,514,018 sucralfate 1 gram tablets. The contract has a ceiling value of $8,282.75 and a period of performance ending on May 7, 2024. The contract is a firm-fixed-price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,101.89, is for the delivery of 420 ml bottles of 1 gm/10 ml Sucralfate suspension. This is a firm-fixed-price delivery order contract that runs through March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,963.24 firm fixed price delivery order is for the provision of 4564118046 - Sucralfate 1 GM/10 ML Suspension Cups, with a completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a ceiling value of $2,107.58. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,622.19 firm fixed-price delivery order is for the supply of 4563892788 ! SUCRALFATE 1 GM/10 ML SUSP 414ML, a pharmaceutical product. The contract has a completion date of March 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTR5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,279.01 firm fixed price delivery order is for the supply of Carafate 1 GM/10 ML suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/13/24 |